|
|
 |
|
KERX: Keryx Biopharmaceuticals Inc - Stock News |
Enter Ticker:
|
|
| Nov 11, 2009 |
AEterna Zentaris Partner, Keryx Biopharmaceuticals, Announces Poster Presentation Highlighting Clinical Activity of Perifosine (KRX-0401) at 51st Annual Meeting of the American Society of Hematology |
| Nov 11, 2009 |
Keryx Biopharmaceuticals Announces Poster Presentation Highlighting Clinical Activity of KRX-0401 (Perifosine) at the 51st Annual Meeting of the American Society of Hematology |
| Nov 10, 2009 |
Conference Calls Today: 3:25-3:40 P.M. EDT |
| Nov 09, 2009 |
Keryx Biopharmaceuticals, Inc. Announces Third Quarter 2009 Financial Results |
| Nov 09, 2009 |
AEterna Zentaris: Scientific Article Supports Perifosine's Development in Kidney Cancer |
| Nov 09, 2009 |
BiomedReports: News and FDA Updates for Ferro (NYSE:FOE), Boston Scientific (NYSE:BSX), Keryx (Nasdaq:KERX) |
| Nov 06, 2009 |
Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Third Quarter 2009 Financial Results on Tuesday, November 10, 2009 at 8:30 a.m. EST |
| Nov 04, 2009 |
Keryx Biopharmaceuticals to Present at the Merriman Curhan Ford 6th Annual Investor Summit |
| Nov 03, 2009 |
AnalystChoice.com Provides Analytical Coverage on DPL, SOL, YHOO,KERX, JACK and HCBK |
| Nov 02, 2009 |
StockProfiler.US: Stock Watch: NASDAQ: NGSX & KERX |
| Oct 29, 2009 |
StockProfiler.US: Stock Watch: NASDAQ: NGSX & KERX |
| Oct 29, 2009 |
Keryx Biopharmaceuticals to Present at the Oppenheimer 20th Annual Healthcare Conference |
| Oct 26, 2009 |
Keryx Biopharmaceuticals, Inc. Announces Upcoming Poster Presentation of Zerenex (ferric citrate) for the Treatment of Hyperphosphatemia at the Upcoming American Society of Nephrology Renal Week Meeting in San Diego |
| Oct 23, 2009 |
RidgewaterEquity.com Free Fundamental Sector & Market Research onKERX, YHOO, GMCR, AINV, FULT and ASBC |
| Oct 19, 2009 |
BUYINS.NET: SCI, WW, ARA, KERX, WMGI, ARLP Expected To Be Higher Leading Up To Next Earnings Releases |
| |
| ZACKS COMMENTARY FOR KERX |
|
|
|